Eisai
4523.T
#1989
Rank
S$10.61 B
Marketcap
$37.61
Share price
-2.74%
Change (1 day)
-30.56%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.96

According to Eisai's latest financial reports the company's current EPS (TTM) is $2.93. In 2022 the company made an earnings per share (EPS) of $2.15 a decrease over its 2021 EPS that were of $9.55.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9637.54%
2022$2.15-77.48%
2021$9.55-41.88%
2020$16.44-0.94%
2019$16.6052.59%
2018$10.88124.17%
2017$4.85-49.42%
2016$9.5937.08%
2015$7.00-11.75%
2014$7.93-3.23%
2013$8.19-18.56%
2012$10.06-15.51%
2011$11.91-3.75%
2010$12.37-1.36%
2009$12.54